Stocks · Health care · Biological Products, (No Diagnostic Substances)

Beam Therapeutics Inc.

BEAM Clue Score48
United States Fiscal year ends December CIK 0001745999 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Giuseppe Ciaramella
17 Jun 2026
President
Exercised, kept
29,000
$1.03
$29.87K
Giuseppe Ciaramella
17 Jun 2026
President
Exercised, kept
6,505
$0.67
$4.36K
Giuseppe Ciaramella
17 Dec 2024
President
Exercised, kept
53,500
$0.67
$35.85K
Giuseppe Ciaramella
20 Oct 2023
President and CSO
Exercised, kept
90,900
$0.67
$60.90K
John M. Evans
31 Mar 2023
CEO
Exercised, kept
13,850
$7.22
$100.00K
Christine Bellon
30 Mar 2023
Chief Legal Officer
Exercised, kept
2,669
$7.22
$19.27K
Christine Bellon
30 Mar 2023
Chief Legal Officer
Exercised, kept
6,272
$7.22
$45.28K
Giuseppe Ciaramella
30 Dec 2022
President & CSO
Exercised, kept
4,500
$0.67
$3.02K
Giuseppe Ciaramella
29 Dec 2021
President & CSO
Exercised, kept
39,700
$0.67
$26.60K
Giuseppe Ciaramella
17 Sep 2021
President & CSO
Exercised, kept
18,012
$0.67
$12.07K
John M. Evans
23 Apr 2021
CEO
Exercised, kept
6,000
$1.03
$6.18K
Giuseppe Ciaramella
5 Mar 2021
President & CSO
Exercised, kept
4,030
$0.67
$2.70K
Giuseppe Ciaramella
30 Sep 2020
President & CSO
Exercised, kept
3,731
$0.67
$2.50K
Showing 250 of 252 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 207
Amendments (4/A) skipped 7
Filings about a different issuer 1
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 61
Sales straight out of an exercise 128
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 55,208,867
Sales filed before the plan box existed 40
History held since 11 Feb 2020